4.3 Article

Regulations on cell therapy products in China: a brief history and current status

Journal

REGENERATIVE MEDICINE
Volume 14, Issue 8, Pages 791-802

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/rme-2019-0069

Keywords

cell therapy; china; clinical trial; legal/regulatory; manufacturing; policy; regulation

Ask authors/readers for more resources

This report describes changes to cell therapy research and clinical practice in China as a result of guidelines from the central government finalized at the end of 2017. The tables list Chinese authorities and regulations on human cells for medical research over the years 1993-2018. Under the new regulations, cell therapy products (CTPs) are treated like drugs, in alignment with policy in the USA and European Union. At civil institutions in China, there are now two pathways for human clinical trials: research versus pharmaceutical development. At the end of 2018, trials of CTPs were only authorized at 114 approved hospitals. It is hoped that the new policies will help CTPs developed in China gain acceptance by health regulators in the west.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Biophysics

Umbilical cord blood donation: public or private?

K. K. Ballen, F. Verter, J. Kurtzberg

BONE MARROW TRANSPLANTATION (2015)

Article Cell & Tissue Engineering

The first decade of advanced cell therapy clinical trials using perinatal cells (2005-2015)

Pedro S. Couto, Alexey Bersenev, Frances Verter

REGENERATIVE MEDICINE (2017)

Article Cell & Tissue Engineering

First decade of clinical trials and published studies with mesenchymal stromal cells from umbilical cord tissue

Pedro S. Couto, Gocha Shatirishvili, Alexey Bersenev, Frances Verter

REGENERATIVE MEDICINE (2019)

Review Biotechnology & Applied Microbiology

Expansion of human mesenchymal stem/stromal cells (hMSCs) in bioreactors using microcarriers: lessons learnt and what the future holds

P. Silva Couto, M. C. Rotondi, A. Bersenev, C. J. Hewitt, A. W. Nienow, F. Verter, Q. A. Rafiq

BIOTECHNOLOGY ADVANCES (2020)

Article Meteorology & Atmospheric Sciences

Skin temperature analysis and bias correction in a coupled land-atmosphere data assimilation system

Michael G. Bosilovich, Jon D. Radakovich, Arlindo da Silva, Ricardo Todling, Frances Verter

JOURNAL OF THE METEOROLOGICAL SOCIETY OF JAPAN (2007)

Article Astronomy & Astrophysics

Infrared properties of molecular cirrus. II. Cloud-to-cloud variations in graphite and polycyclic aromatic hydrocarbon content

F Verter, L Magnani, E Dwek, LJ Rickard

ASTROPHYSICAL JOURNAL (2000)

No Data Available